Literature DB >> 10918331

Contrast-enhanced MRI for the assessment of myocardial viability after permanent coronary artery occlusion.

R S Pereira1, F S Prato, K S Lekx, J Sykes, G Wisenberg.   

Abstract

Previous studies in a model of ischemia/reperfusion using a constant infusion of Gd-DTPA have shown that distribution volume (lambda) is increased in infarcted myocardial tissue. This study examined this technique in the setting of permanent coronary artery occlusion. Ten beagles underwent permanent occlusion of a coronary artery for 2 days (N = 3), 1 week (N = 4), or 3 weeks (N = 3). Imaging was performed at 2 days and, depending on the length of occlusion, 1 week, 2 weeks, and 3 weeks to follow changes in lambda in vivo. At sacrifice, (201)Tl was injected and the extent of the hyperenhanced region was compared to pathology. lambda was increased in infarcted tissue by 2 days post occlusion and this increase persisted for 3 weeks. At sacrifice, lambda correlated strongly with (201)Tl uptake (r = -0.86 to -0.95, P < 0.05; i.e., lambda increased in infarcted tissue) and the size of the hyperenhanced region was comparable to pathological infarct size (slope 1.006, r = 0.96, P < 0.0001). Thus, beyond 2 days after coronary occlusion, MRI, during a constant infusion of Gd-DTPA, can assess myocardial viability regardless of the success of reperfusion. Magn Reson Med 44:309-316, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918331     DOI: 10.1002/1522-2594(200008)44:2<309::aid-mrm19>3.0.co;2-2

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  8 in total

1.  Collateral circulation formation determines the characteristic profiles of contrast-enhanced MRI in the infarcted myocardium of pigs.

Authors:  Jian Wang; Bo Xiang; Hung-yu Lin; Hong-yu Liu; Darren Freed; Rakesh C Arora; Gang-hong Tian
Journal:  Acta Pharmacol Sin       Date:  2015-03-23       Impact factor: 6.150

2.  A comparison of CH3-DTPA-GD (NMS60) and GD-DTPA for evaluation of acute myocardial ischemia.

Authors:  H E D'Arceuil; A J de Crespigny; L Pelc; D Howard; S Seri; Y Hashiguchi; A Nakatani; M E Moseley
Journal:  Int J Cardiovasc Imaging       Date:  2005-10       Impact factor: 2.357

3.  Quantitation of the thickness of the non-enhanced myocardial rim predicts recovery of territorial myocardial function in chronic ischemic heart disease: a cardiac magnetic resonance imaging study.

Authors:  Tienush Rassaf; Johannes Nolte; Nicole Heussen; Gaby A Krombach; Rolf W Günther; Malte Kelm; Harald P Kühl
Journal:  Clin Res Cardiol       Date:  2010-02-12       Impact factor: 5.460

4.  Cardiac magnetic resonance imaging: long term reproducibility of the late enhancement signal in patients with chronic coronary artery disease.

Authors:  H Bülow; C Klein; I Kuehn; R Hollweck; S G Nekolla; K Schreiber; F Haas; J Böhm; B Schnackenburg; R Lange; M Schwaiger
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

5.  Mapping myocardial viability using interleaved T1-T2* weighted imaging.

Authors:  Gang Li; Guangping Dai; Bo Xiang; John Mark; Boguslaw Tomanek; Hongyu Liu; Roxanne Deslauriers; Ganghong Tian
Journal:  Int J Cardiovasc Imaging       Date:  2004-04       Impact factor: 2.357

6.  Clinical assessment of myocardial viability using MRI during a constant infusion of Gd-DTPA.

Authors:  R S Pereira; G Wisenberg; F S Prato; K Yvorchuk
Journal:  MAGMA       Date:  2000-12       Impact factor: 2.533

7.  Cell tracking and therapy evaluation of bone marrow monocytes and stromal cells using SPECT and CMR in a canine model of myocardial infarction.

Authors:  Gerald Wisenberg; Katie Lekx; Pam Zabel; Huafu Kong; Rupinder Mann; Peter R Zeman; Sudip Datta; Caroline N Culshaw; Peter Merrifield; Yves Bureau; Glenn Wells; Jane Sykes; Frank S Prato
Journal:  J Cardiovasc Magn Reson       Date:  2009-04-27       Impact factor: 5.364

Review 8.  Targeting myocardial ischaemic injury in the absence of reperfusion.

Authors:  M V Basalay; D M Yellon; S M Davidson
Journal:  Basic Res Cardiol       Date:  2020-10-14       Impact factor: 17.165

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.